PF420 RESULTS OF A PROSPECTIVE MULTICENTER STUDY ON PRO-ATHEROTHROMBOTIC EFFECT INDUCED BY TYROSINE-KINASE INHIBITORS FOR FIRST-LINE TREATMENT OF CML PTS (KIARO TRIAL)

Autor: Alessandra Iurlo, Daniele Cattaneo, Nicola Sgherza, Luigiana Luciano, Antonella Gozzini, Giorgina Specchia, Luca Puccetti, Monica Bocchia, S. Ciofini, Sara Galimberti, Elisabetta Abruzzese, Anna Sicuranza, C. Zuanelli Brambilla, Ilaria Ferrigno, Fabio Stagno

Publikováno v: HemaSphere. 3:163-164

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::84fc61f615aeec1ea2bbc3f5b52a19a9
https://doi.org/10.1097/01.hs9.0000559892.28745.7b

Bortezomib based therapies and High Cut Off filter dyalysis (HCO) are effective in Multiple Myeloma patients with end stage renal failure

Autor: Alessandro Gozzetti, Veronica Candi, F. Bacchiarri, C. Zuanelli Brambilla, Giulia Papini, Monica Bocchia, Alberto Bosi, Chiara Nozzoli

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 15:e135

6.02 (5.35-17.45); 3 IgG : 0.45 (0.15-1.07)) and 3 IgA (2.51 (1.994.94) which was not detected by IFE. In 9/9 patients the abnormal HLC ratio was seen in concordance with the clonality identified by FLC and in 7/9 patients the ratio was abnormal due

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::034f9f16219ee236f2aeada348387a00
https://doi.org/10.1016/j.clml.2015.07.332

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation.

Autor: Shouval R; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York., Waters NR; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York., Gomes ALC; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York., Zuanelli Brambilla C; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medical Biotechnologies, University of Siena, Siena, Italy.; Hematology Unit, Department of Oncology, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Fei T; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Devlin SM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Nguyen CL; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York., Markey KA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Dai A; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York., Slingerland JB; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York., Clurman AG; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York., Fontana E; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Amoretti LA; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Wright RJ; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Hohl TM; Department of Medicine, Weill Cornell Medical College, New York, New York.; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Taur Y; Department of Medicine, Weill Cornell Medical College, New York, New York.; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Weber D; Department of Internal Medicine, University Medical Center, University of Regensburg, Regensburg, Germany., Hashimoto D; Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan., Teshima T; Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan., Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Holler E; Department of Internal Medicine, University Medical Center, University of Regensburg, Regensburg, Germany., Scordo M; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York., Giralt SA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York., Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York., Peled JU; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York., van den Brink MRM; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jan 04; Vol. 29 (1), pp. 165-173.